Crinetics Pharmaceuticals (CRNX) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-1.22 and quarterly revenue of $8.13M.
In the most recent quarter (Q4), Crinetics Pharmaceuticals reported EPS of $-1.29, beating estimates of $-1.37 by 0.06%. Revenue came in at $6.16M, exceeding the estimate of $4.63M by 0.33%.
Over the last 4 quarters, Crinetics Pharmaceuticals has averaged an EPS surprise of 0.09% and a revenue surprise of 1.10%.
Analyze the earnings history of Crinetics Pharmaceuticals using advanced sorting and filters.
The chart below shows Crinetics Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Crinetics Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
Crinetics Pharmaceuticals (CRNX) is scheduled to report earnings on May 7, 2026. The last reported earnings were for reported on February 26, 2026 for Q4.
The Actual EPS was $-1.29, which beat the estimate of $-1.37.
The Actual Revenue was $6.16M, which beat the estimate of $4.63M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-02-26 | $-1.29 | $-1.37 | 5.84 % |
| Q3 | 2025-11-06 | $-1.38 | $-1.26 | -9.52 % |
| Q2 | 2025-08-07 | $-1.23 | $-1.11 | -10.8 % |
| Q1 | 2025-05-08 | $-1.04 | $-0.95 | -9.47 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-02-26 | $6.16M | $4.63M | 33.1 % |
| Q3 | 2025-11-06 | $143.00K | $1.32M | -89.1 % |
| Q2 | 2025-08-07 | $1.03M | $2.33M | -55.8 % |
| Q1 | 2025-05-08 | $361.00K | $100.00K | 261.0 % |